Stock Analiz

enGene Therapeutics Inc. (ENGN) stock forecast and price target

Price $2.41 · data as of November 13, 2026

12-month price target

Average target$4.29
Upside / downside+77.8%
Analysts7
ConsensusBuy
Low $2.00Average $4.29High $6.00

Gold marker: average target · white marker: today’s price ($2.41)

Analyst ratings

Strong buy 2Buy 4Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Next fiscal year
ends October 31, 2027
$-1.59+12.4%$5M
Quarter after
ends January 31, 2027
$-0.38+14.4%$0

Consensus of the analysts covering enGene Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 6 lowered.

Frequently asked questions

What is the enGene Therapeutics stock price target?

The average 12-month target from 7 analysts is $4.29, 77.8% above the current price of $2.41 Targets range from $2.00 to $6.00.

Is enGene Therapeutics a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 4 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.